Origene
ent_fb64833e2bce99da
Disclosures
2
Leak Site · 1 jurisdiction
Incidents
—
no linked incident in sample
Max affected reported
—
no filed count in sample
Leak-site claims
2
unverified actor claims
Identity resolution
- Canonical name
- Origene
- Normalized
- origene— dedupe via name-norm; Microsoft / MSFT collapse to one row
- GLEIF LEI
- No match
- SEC EDGAR CIK
- None — not an SEC registrant
- Domain
- origene.com
Unverified threat-actor claim — not a regulatory filing
Attribution, victim identity, and counts shown here derive from a threat actor's public extortion-blog claims, aggregated by ransomware.live. They have not been validated by the victim or any regulator. Treat them as the threat actor's assertion until a regulatory filing or victim disclosure corroborates them.
Disclosure history (2)newest first
- GLOBALLeak Siteas victim2025-02-03
Origene Technologies Inc. is a biotechnological company that specializes in innovative gene-related research and other customized research areas for the scientific community. Their primary focus includes antibody development, gene synthesis, CRISPR tools, and other experimental models. Founded in 1996 and headquartered in Rockville, Maryland, U.S., Origene operates globally and offers its products and solutions to a wide range of industries like pharmaceuticals, diagnostics, academia, and more.
- GLOBALLeak Siteas victim2025-02-03
OriGene Technologies is a leading biotechnological firm based in Rockville, USA. The company specializes in creating unique products for genomic and proteomic research, including antibodies, vectors, CRISPR, proteins, assays and cDNA clones. Further, it supports disease-based research, drug development efforts and diagnostic applications. By providing comprehensive tools in support of the global scientific community, OriGene seeks to improve the understanding of biological processes and the development of efficacious therapeutics.